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Predicting the Development of Hemolytic
Disease of the Newborn in ABO Incompatibility?We read with great interest the article by Valsami et al1 that re-
ported the importance of the direct antiglobulin test (DAT) in cord
blood for predicting the development of hemolytic disease of the
newborn (HDN). They concluded that, although ABO in-
compatibility remains the main cause of a positive DAT, other
causes, such as alloimmunization and drug interactions should also
be investigated. In addition, they suggested that the relevant
impact of DAT positivity on the development of HDN should be
considered. Although we agree with their conclusion, we think that
the study has many limitations and therefore, we would like to
make some constructive comments on their article.
Firstly, although they mentioned that a positive DAT in ABO in-
compatibility is considered a major risk factor for the development
of severe HDN, they did not present data for a control groupwho had
negativeDATs. By contrast, the positive predictive value of a positive
DAT for the development of HDN is as low as 23%.2 This is due to
several factors: (1) the expression of A and B blood group antigens on
fetal red blood cells (RBCs) is low; (2) ABO antibodies are mainly of
the immunoglobulin G2 subtype, which cannot destroy RBCs
intensely; and (3) ABO antigens are present on many tissues other
than RBCs, resulting in a lowbinding level of these antibodies to RBCs
and therefore, less severe hemolysis.3
Secondly, it is interesting to note that no case of positive DAT
was attributed to rhesus (Rh) alloimmunization in their study.
However, the severity of HDN in Rh alloimmunization is generally
well correlated with DAT positivity; hence, some cases could be
expected whose positive DATs are related to Rh alloimmunization
because the concomitant presence of ABO isoimmunization and Rh
alloimmunization has a milder HDN severity than Rh alloimmuni-
zation alone. They reported four cases of A/O group in-
compatibility with positive DATs who were also Rh-positive infants
born to Rh-negative mothers. DAT positivity in these cases was
attributed to ABO incompatibility. However, this was possibly due
to the destruction of some erythrocytes by natural ABO isoagglu-
tinin; therefore, a less aggressive Rh alloimmunization reaction
ensued.
Finally, there is no information related to antenatal screening
of these cases for fetal anemia and, hence, if any of the patients
needed transfusion. In addition, there is no information related to
evaluation of the morphologic features of erythrocytes.
In summary, all newborn infants, particularly those with blood
group incompatibility, should be monitored for jaundice early inhttp://dx.doi.org/10.1016/j.pedneo.2015.11.006
1875-9572/Copyrightª 2016, Taiwan Pediatric Association. Published by
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).life. DAT alone is an unreliable marker to predict the development
of HDN, particularly in newborns with ABO incompatibility.
Therefore, the combined use of the DAT with clinical findings, red
blood cell indices, and a blood smear would be more beneficial
than the use of the DAT alone for predicting the development and
severity of HDN, particularly in cases of ABO incompatibility.
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